<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Features Australia

Covid’s warped model

Injured people mean big business for Big Pharma

19 January 2023

9:00 AM

19 January 2023

9:00 AM

‘Is curing patients a sustainable business model?’ That’s what Goldman Sachs analysts asked in an April 2018 report on ‘The Genome Revolution’. The analysts didn’t think so, arguing that there was little money to be made on ‘one shot cures’. But there is endless money to be made from chronically injured people, they argued.

Already a subscriber? Log in

Subscribe for just $2 a week

Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.

  • Unlimited access to spectator.com.au and app
  • The weekly edition on the Spectator Australia app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk

Unlock this article


You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.


Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in